Limited expression of cancer-testis antigens in renal cell carcinoma patients

由 SOGA, NORIHITO, HORI, YASUHIDE, YAMAKADO, KOICHIRO, IKEDA, HIROAKI, IMAI, NAOKO, KAGEYAMA, SHINICHI, NAKASE, KAZUNORI, YUTA, ATSUSHI, HAYASHI, NORIO, SHIKU, HIROSHI, SUGIMURA, YOSHIKI
出版 2013

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

由 Ishihara, Mikiya, Tono, Yasutaka, Miyahara, Yoshihiro, Muraoka, Daisuke, Harada, Naozumi, Kageyama, Shinichi, Sasaki, Takeshi, Hori, Yasuhide, Soga, Norihito, Uchida, Katsunori, Shiraishi, Taizo, Sato, Eiichi, Kanda, Hideki, Mizuno, Toshiro, Webster, Gill A., Ikeda, Hiroaki, Katayama, Naoyuki, Sugimura, Yoshiki, Shiku, Hiroshi
發表在 Cancer Immunol Immunother (2020)